Export 29 results:
Auteur Title Type [ Année(Asc)]
Filtres: Auteur is Plitman, Eric  [Enlever les filtres]
Takamiya A, Plitman E, Chung JKu, M Chakravarty M, Graff-Guerrero A, Mimura M, Kishimoto T.  2019.  Acute and long-term effects of electroconvulsive therapy on human dentate gyrus.. Neuropsychopharmacology.
Copersino ML, Patel R, Price JS, Visser KFrost, Vitaliano G, Plitman E, Lukas SE, Weiss RD, Janes AC, M Chakravarty M.  2019.  Interactive effects of age and recent substance use on striatal shape morphology at substance use disorder treatment entry.. Drug Alcohol Depend. :107728.
Tarumi R, Tsugawa S, Noda Y, Plitman E, Honda S, Matsushita K, Chavez S, Sawada K, Wada M, Matsui M et al..  2019.  Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study.. Neuropsychopharmacology.
Kim J, Plitman E, Iwata Y, Nakajima S, Mar W, Patel R, Chavez S, Chung JKu, Caravaggio F, M Chakravarty M et al..  2019.  Neuroanatomical profiles of treatment-resistance in patients with schizophrenia spectrum disorders.. Prog Neuropsychopharmacol Biol Psychiatry. :109839.
Wada M, Kurose S, Miyazaki T, Nakajima S, Masuda F, Mimura Y, Nishida H, Ogyu K, Tsugawa S, Mashima Y et al..  2019.  The P300 event-related potential in bipolar disorder: A systematic review and meta-analysis.. J Affect Disord. 256:234-249.
Guma E, Plitman E, M Chakravarty M.  2019.  The role of maternal immune activation in altering the neurodevelopmental trajectories of offspring: A translational review of neuroimaging studies with implications for autism spectrum disorder and schizophrenia.. Neurosci Biobehav Rev. 104:141-157.
Plitman E, Guma E, Lepage M, Near J, M Chakravarty M.  2019.  Using proton magnetic resonance spectroscopic imaging to study glutamatergic alterations in patients with schizophrenia: A systematic review.. Schizophr Res. 210:13-20.
Winterburn JL, Voineskos AN, Devenyi GA, Plitman E, de la Fuente-Sandoval C, Bhagwat N, Graff-Guerrero A, Knight J, M Chakravarty M.  2017.  Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study. Schizophr Res.
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Shinagawa S, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Patel R et al..  2017.  The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.. J Alzheimers Dis. 60(2):341-347.
Chung JKu, Plitman E, Nakajima S, Caravaggio F, Iwata Y, Gerretsen P, Kim J, Takeuchi H, Shinagawa S, Patel R et al..  2017.  Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.. J Alzheimers Dis. 58(3):747-762.
Caravaggio F, Gerretsen P, Mar W, Chung JKu, Plitman E, Nakajima S, Kim J, Iwata Y, Patel R, M Chakravarty M et al..  2017.  Intranasal oxytocin does not modulate jumping to conclusions in schizophrenia: Potential interactions with caudate volume and baseline social functioning.. Psychoneuroendocrinology. 81:80-87.
Plitman E, Iwata Y, Caravaggio F, Nakajima S, Chung JKu, Gerretsen P, Kim J, Takeuchi H, M Chakravarty M, Remington G et al..  2017.  Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis.. Schizophr Bull.
Caravaggio F, Chung JKu, Plitman E, Boileau I, Gerretsen P, Kim J, Iwata Y, Patel R, M Chakravarty M, Remington G et al..  2017.  The relationship between subcortical brain volume and striatal dopamine D2/3 receptor availability in healthy humans assessed with [(11) C]-raclopride and [(11) C]-(+)-PHNO PET.. Hum Brain Mapp. 38(11):5519-5534.
Caravaggio F, Plitman E, Chung JKu, Gerretsen P, Kim J, Iwata Y, M Chakravarty M, Remington G, Graff-Guerrero A.  2017.  Trait impulsiveness is related to smaller post-commissural putamen volumes in males but not females.. Eur J Neurosci. 46(7):2253-2264.